First Time Loading...

Shanghai Medicilon Inc
SSE:688202

Watchlist Manager
Shanghai Medicilon Inc Logo
Shanghai Medicilon Inc
SSE:688202
Watchlist
Price: 35.36 CNY -1.81% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

Price Targets Summary
Shanghai Medicilon Inc

There are no price targets for Shanghai Medicilon Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Shanghai Medicilon Inc Competitors:
Price Targets
4880
CellSource Co Ltd
22% Upside
301333
R&G PharmaStudies Co Ltd
37% Upside
TECH
Bio-Techne Corp
6% Upside
HVO
hVIVO PLC
31% Upside
ABSI
Absci Corp
73% Upside
TMO
Thermo Fisher Scientific Inc
10% Upside
MEDP
Medpace Holdings Inc
17% Upside
MLC
Malin Corporation PLC
44% Upside

Revenue
Forecast

Revenue Estimate
Shanghai Medicilon Inc

For the last 5 years the compound annual growth rate for Shanghai Medicilon Inc's revenue is 46%. The projected CAGR for the next 3 years is 14%.

46%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shanghai Medicilon Inc

For the last 5 years the compound annual growth rate for Shanghai Medicilon Inc's operating income is 48%. The projected CAGR for the next 2 years is -42%.

48%
Past Growth
-42%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Shanghai Medicilon Inc

For the last 5 years the compound annual growth rate for Shanghai Medicilon Inc's net income is 52%. The projected CAGR for the next 3 years is -4%.

52%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Medicilon Inc's stock price target?
Not Available

Shanghai Medicilon Inc doesn't have any price targets made by Wall Street professionals.

What is Shanghai Medicilon Inc's Revenue forecast?
Projected CAGR
14%

For the last 5 years the compound annual growth rate for Shanghai Medicilon Inc's revenue is 46%. The projected CAGR for the next 3 years is 14%.

What is Shanghai Medicilon Inc's Operating Income forecast?
Projected CAGR
-42%

For the last 5 years the compound annual growth rate for Shanghai Medicilon Inc's operating income is 48%. The projected CAGR for the next 2 years is -42%.

What is Shanghai Medicilon Inc's Net Income forecast?
Projected CAGR
-4%

For the last 5 years the compound annual growth rate for Shanghai Medicilon Inc's net income is 52%. The projected CAGR for the next 3 years is -4%.